Parmentier, S.
Melin, Jacques
[UCL]
Piret, L.
Beckers, Christian
[UCL]
Abnormalities in left ventricular filling have been described as an early finding in coronary artery disease and in cardiomyopathy. The present study was undertaken to determine whether impaired diastolic function may be an early sign of anthracycline cardiotoxicity. Radionuclide left ventricular curves of 30 treated patients were compared with the curves of 17 normal, agematched, volunteers. The curves were analyzed for ejection fraction, peak filling rate (normalized for end diastolic counts and for stroke counts), time to peak filling rate and filling fraction in the first third of diastole normalized for cycle length. In 20 patients (Groups A and B), we analyzed the radionuclide ventriculography preceding the decrease of systolic function or a clinical congestive heart failure. In ten patients (Group C) who ended a treatment regimen without systolic dysfunction or clinically evident cardiotoxicity, we analyzed the ventriculography at the end of the therapy. Among the diastolic indexes, only the first third filling fraction was abnormal in a minority of the patients (6/20 in Groups A and B). Our findings suggest that diastolic dysfunction is uncommon in anthracycline treated patients prior to systolic dysfunction.
- Alexander J, Dainiak N, Berger HJ, Goldman L, Hohnstone D, Reduto L, Duffy T, Schwartz P, Gottschalk A, Zaret BL (1979) Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography. N Engl J Med 300:278–283
- Bachur NR (1979) Anthracycline antibiotics: pharmacology and metabolism. Cancer Treat Rep 63:817–820
- Bonfante V, Ferrari L, Brambilla C, Rossi A, Villani F, Crippa F, Valagussa P, Bonadonna G (1986) New anthracycline analogs in advanced breast cancer. Eur J Cancer Oncol 22:1379–1385
- Bonow R. O., Rosing D. R., Bacharach S. L., Green M. V., Kent K. M., Lipson L. C., Maron B. J., Leon M. B., Epstein S. E., Effects of verapamil on left ventricular systolic function and diastolic filling in patients with hypertrophic cardiomyopathy, 10.1161/01.cir.64.4.787
- Bonow R. O., Bacharach S. L., Green M. V., Kent K. M., Rosing D. R., Lipson L. C., Leon M. B., Epstein S. E., Impaired left ventricular diastolic filling in patients with coronary artery disease: assessment with radionuclide angiography, 10.1161/01.cir.64.2.315
- Bourdillon P. D., Lorell B. H., Mirsky I., Paulus W. J., Wynne J., Grossman W., Increased regional myocardial stiffness of the left ventricle during pacing-induced angina in man, 10.1161/01.cir.67.2.316
- Bristow MR, Billingham ME, Mason JW, Daniels JR (1978) Clinical spectrum of anthracycline antibiotic cardiotoxicity. Cancer Chemother Rep 6:195–201
- Bristow MR, Mason JW, Billingham ME, Daniels JR (1981) Doseeffect and structure-function relationships in doxorubicin cardiomyopathy. Am Heart J 102:709–718
- Carter SK (1975) Adriamycine: a review. J Natl Canc Inst 55:1265–1274
- Choi BW, Berger HJ, Schwartz PE, Alexander J, Wackers FIT, Gottschalk A, Zaret BL (1983) Serial radionuclide assessment of doxorubicin cardiotoxicity in cancer patients with abnormal baseline resting left ventricular performance. Am Heart J 106:638–643
- De Kock M, Melin JA, Nannan ME, Robert A, Beckers C, Lavenne F, Detry JMR (1986) Alteration of left ventricular diastolic filling in hypertensive patients: effects of nitrendipine and atenolol. Eur Heart J 7:792–799
- GOTTDIENER JOHN S., Doxorubicin Cardiotoxicity: Assessment of Late Left Ventricular Dysfunction By Radionuclide Cineangiography, 10.7326/0003-4819-94-4-430
- Inouye I, Massie B, Loge D, Topic N, Silverstein D, Simpson P, Tubau J (1984) Abnormal left ventricular filling: an early finding in mild to moderate systemic hypertension. Am J Cardiol 53:120–126
- Jain KK, Casper ES, Geller NL, Hakes TB, Kaufman RJ, Currie V, Schwartz W, Cassidy C, Petroni GR, Young CW, Wittes RE (1985) A prospective randomized comparison of epirubicin and doxorubicin in patients with advanced breast cancer. J Clin Oncol 3:818–826
- Lee Bang Hun, Goodenday Lucy S., Muswick Gary J., Yasnoff William A., Leighton Richard F., Skell Roland T., Alterations in left ventricular diastolic function with doxorubicin therapy, 10.1016/s0735-1097(87)80099-2
- Maral RJ, Jouanne M (1981) Toxicology of daunorubicin in animals and man. Cancer Treat Rep 65:9–18
- Minow RA, Benjamin RS, Lee ET, Gottlieb JA (1977) Adriamycin cardiomyopathy - risk factors. Cancer 39:1397–1402
- Polak JF, Kemper AJ, Bianco JA, Parisi AF, Tow DE (1981) Resting early peak diastolic filling rate: a sensitive index of myocardial dysfunction in patients with coronary artery disease. J Nucl Med 23:471–478
- Ritchie JL, Singer JW, Thorning D, Sorensen SG, Hamilton GW (1980) Anthracycline cardiotoxicity: clinical and pathologic outcomes assessed by radionuclide ejection fraction. Cancer 46:1109–1116
- Singer JW, Narahara KA, Ritchie JL, Hamilton GW, Kennedy JW (1978) Time- and dose-dependent changes in ejection fraction determined by radionuclide angiography after anthracycline therapy. Cancer Treat Rep 62:945–948
- Soufer R, Wohlgelernter D, Vita N (1985) Intact systolic left ventricular function in clinical congestive heart failure. Am J Cardiol 55:1032–1036
- Topol EJ, Tarill TA, Fortuin NJ (1985) Hypertensive hypertrophic cardiomyopathy of the elderly. N Engl J Med 312:277–283
Bibliographic reference |
Parmentier, S. ; Melin, Jacques ; Piret, L. ; Beckers, Christian. Assessment of left ventricular diastolic function in patients receiving anthracycline therapy.. In: European journal of nuclear medicine, Vol. 13, no. 11, p. 563-7 (1988) |
Permanent URL |
http://hdl.handle.net/2078.1/14025 |